| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36
|
Zhu, Weifei
|
|
|
119 |
25 |
p. 6136-6144
|
artikel
|
| 2 |
A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13
|
Schiviz, Alexandra
|
|
|
119 |
25 |
p. 6128-6135
|
artikel
|
| 3 |
Are all mutant SNARES equal?
|
McClain, Kenneth L.
|
|
|
119 |
25 |
p. 5944-5945
|
artikel
|
| 4 |
A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer
|
Elvington, Michelle
|
|
|
119 |
25 |
p. 6043-6051
|
artikel
|
| 5 |
Baby, it's cold outside!
|
Gertz, Morie A.
|
|
|
119 |
25 |
p. 5943-5944
|
artikel
|
| 6 |
BH3 mimetics and multi-kinase inhibition in AML
|
Beauchamp, Elspeth M.
|
|
|
119 |
25 |
p. 5947-5948
|
artikel
|
| 7 |
BMP9 and BMP10 are critical for postnatal retinal vascular remodeling
|
Ricard, Nicolas
|
|
|
119 |
25 |
p. 6162-6171
|
artikel
|
| 8 |
Boosting antibody therapy with complement
|
Boross, Peter
|
|
|
119 |
25 |
p. 5945-5947
|
artikel
|
| 9 |
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia
|
Blum, William
|
|
|
119 |
25 |
p. 6025-6031
|
artikel
|
| 10 |
CNS hyperleukocytosis
|
Munoz, Javier
|
|
|
119 |
25 |
p. 5953
|
artikel
|
| 11 |
Dasatinib enhances the expansion of CD56+CD3− NK cells from cord blood
|
Tanaka, Junji
|
|
|
119 |
25 |
p. 6175-6176
|
artikel
|
| 12 |
Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet
|
Guilhot, Joëlle
|
|
|
119 |
25 |
p. 5963-5971
|
artikel
|
| 13 |
Development of myeloproliferative disease in 12/15-lipoxygenase deficiency
|
Taylor, Philip R.
|
|
|
119 |
25 |
p. 6173-6174
|
artikel
|
| 14 |
Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)
|
Pagel, Julia
|
|
|
119 |
25 |
p. 6016-6024
|
artikel
|
| 15 |
DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues
|
Poulin, Lionel F.
|
|
|
119 |
25 |
p. 6052-6062
|
artikel
|
| 16 |
Editorial Board
|
|
|
|
119 |
25 |
p. i
|
artikel
|
| 17 |
Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study
|
Proctor, Stephen J.
|
|
|
119 |
25 |
p. 6005-6015
|
artikel
|
| 18 |
Expression of COX-2 on Reed-Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD
|
Mestre, Francisco
|
|
|
119 |
25 |
p. 6072-6079
|
artikel
|
| 19 |
How I treat pediatric acute myeloid leukemia
|
Rubnitz, Jeffrey E.
|
|
|
119 |
25 |
p. 5980-5988
|
artikel
|
| 20 |
Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia
|
Veys, Paul
|
|
|
119 |
25 |
p. 6155-6161
|
artikel
|
| 21 |
“Inactivating” PF4: a new approach to HIT treatment?
|
Aster, Richard H.
|
|
|
119 |
25 |
p. 5951-5952
|
artikel
|
| 22 |
Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process
|
Rahmani, Mohamed
|
|
|
119 |
25 |
p. 6089-6098
|
artikel
|
| 23 |
Inhibition of the mTORC2 and chaperone pathways to treat leukemia
|
Zhang, Fan
|
|
|
119 |
25 |
p. 6080-6088
|
artikel
|
| 24 |
Long-term outcome of higher-risk MDS patients treated with azacitidine: an update of the GFM compassionate program cohort
|
Itzykson, Raphael
|
|
|
119 |
25 |
p. 6172-6173
|
artikel
|
| 25 |
Losing a “nucleus” to gain a cytoplasm
|
Palis, James
|
|
|
119 |
25 |
p. 5948-5949
|
artikel
|
| 26 |
Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis
|
Jerez, Andres
|
|
|
119 |
25 |
p. 6109-6117
|
artikel
|
| 27 |
Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey
|
Terrier, Benjamin
|
|
|
119 |
25 |
p. 5996-6004
|
artikel
|
| 28 |
Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia
|
Patel, Vivek L.
|
|
|
119 |
25 |
p. 5989-5995
|
artikel
|
| 29 |
Polyphosphate: an ancient molecule that links platelets, coagulation, and inflammation
|
Morrissey, James H.
|
|
|
119 |
25 |
p. 5972-5979
|
artikel
|
| 30 |
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
|
Arai, Sally
|
|
|
119 |
25 |
p. 6145-6154
|
artikel
|
| 31 |
Rational design and characterization of platelet factor 4 antagonists for the study of heparin-induced thrombocytopenia
|
Sachais, Bruce S.
|
|
|
119 |
25 |
p. 5955-5962
|
artikel
|
| 32 |
Response: hematopoietic defects in 12/15-lipoxygenase–deficient mice
|
Puré, Ellen
|
|
|
119 |
25 |
p. 6174-6175
|
artikel
|
| 33 |
Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10
|
Oakley, Kevin
|
|
|
119 |
25 |
p. 6099-6108
|
artikel
|
| 34 |
Signaling and cytoskeletal requirements in erythroblast enucleation
|
Konstantinidis, Diamantis G.
|
|
|
119 |
25 |
p. 6118-6127
|
artikel
|
| 35 |
Targeting antiapoptotic A1/Bfl-1 by in vivo RNAi reveals multiple roles in leukocyte development in mice
|
Ottina, Eleonora
|
|
|
119 |
25 |
p. 6032-6042
|
artikel
|
| 36 |
The platelet “sugar high” in diabetes
|
Ni, Heyu
|
|
|
119 |
25 |
p. 5949-5951
|
artikel
|
| 37 |
Tissue-specific differentiation of a circulating CCR9− pDC-like common dendritic cell precursor
|
Schlitzer, Andreas
|
|
|
119 |
25 |
p. 6063-6071
|
artikel
|
Tijdschrift beschrijving